Mary Kay Fenton
2023 - Tourmaline Bio
In 2023, Mary Kay Fenton earned a total compensation of $1.9M as Former Interim Chief Executive Officer and President and Chief Financial Officer at Tourmaline Bio, a 13% decrease compared to previous year.
Compensation breakdown
| Bonus | $236,600 |
|---|---|
| Option Awards | $363,000 |
| Salary | $390,242 |
| Other | $928,182 |
| Total | $1,918,024 |
Fenton received $928.2K in other compensation, accounting for 48% of the total pay in 2023.
Fenton also received $236.6K in bonus, $363K in option awards and $390.2K in salary.
Rankings
In 2023, Mary Kay Fenton's compensation ranked 553rd out of 2,910 executives tracked by ExecPay. In other words, Fenton earned more than 81.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 553 out of 2,910 | 81st |
Division Manufacturing | 316 out of 1,602 | 80th |
Major group Chemicals And Allied Products | 220 out of 901 | 76th |
Industry group Drugs | 217 out of 864 | 75th |
Industry Biological Products, Except Diagnostic Substances | 76 out of 211 | 64th |
Source: SEC filing on April 19, 2024.
Fenton's colleagues
We found six more compensation records of executives who worked with Mary Kay Fenton at Tourmaline Bio in 2023.
2023
Scott Requadt
Tourmaline Bio
Chief Executive Officer
2023
Sandeep Kulkarni
Tourmaline Bio
Chief Executive Officer
2023
Michael Zdanowski
Tourmaline Bio
Chief Technology Officer
2023
Nancy Krieger
Tourmaline Bio
Chief Medical Officer
2023
Yung Chyung
Tourmaline Bio
Chief Medical Officer
2023
Kevin Johnson
Tourmaline Bio